Instil Bio
TIL
TIL
62 hedge funds and large institutions have $45.3M invested in Instil Bio in 2023 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 25 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $60.9M → $45.3M (-$15.6M)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
68% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 25
Holders
62
Holding in Top 10
2
Calls
$6K
Puts
$1K
Top Buyers
| 1 | +$291K | |
| 2 | +$248K | |
| 3 | +$169K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$118K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$113K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$1.82M | |
| 3 | -$596K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$355K |
| 5 |
JPMorgan Chase & Co
New York
|
-$278K |